Home › Funds › Patient Square Capital LP › CCCC
Patient Square Capital LP position in CCCC
C4 THERAPEUTICS INC · Health Care
Patient Square Capital LP reported holding 1,608,815 shares of CCCC (C4 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.5M, representing 1.16% of its reported portfolio and ranking #20 among its reported holdings. Patient Square Capital LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Patient Square Capital LP's CCCC position evolved
Patient Square Capital LP first disclosed a stake in CCCC in Q2 2026 at 1,608,815 shares (US$7.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.61M | $7.51M | New |
About CCCC and 13F data
CCCC (C4 THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in CCCC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$37.4M), Lynx1 Capital Management LP (US$34.2M), Bain Capital Life Sciences Investors, LLC (US$33.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CCCC
- RA CAPITAL MANAGEMENT, L.P. 8.00M sh · $37.36M · Q2 2026
- Lynx1 Capital Management LP 7.33M sh · $34.22M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 7.17M sh · $33.49M · Q2 2026
- Soleus Capital Management, L.P. 3.38M sh · $15.78M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 3.03M sh · $14.16M · Q2 2026
- Ikarian Capital, LLC 2.43M sh · $11.36M · Q2 2026
- HighVista Strategies LLC 1.35M sh · $6.30M · Q2 2026
- Velan Capital Investment Management LP 570.00K sh · $2.66M · Q2 2026
- Squadron Capital Management LLC 400.00K sh · $1.87M · Q2 2026
- Seven Fleet Capital Management LP 381.17K sh · $1.78M · Q2 2026
More on Patient Square Capital LP
FAQ
How long has Patient Square Capital LP held CCCC?
Patient Square Capital LP has disclosed CCCC holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Patient Square Capital LP's current position in CCCC?
As of Q2 2026, Patient Square Capital LP holds 1.61M shares of CCCC (C4 THERAPEUTICS INC), valued at $7.51M, representing 1.16% of its reported portfolio and ranking #20.
Has Patient Square Capital LP been buying or selling CCCC?
In the latest 13F filing (Q2 2026), Patient Square Capital LP newly opened its position in CCCC.
Which other funds hold CCCC?
Other major institutional holders of CCCC include RA CAPITAL MANAGEMENT, L.P., Lynx1 Capital Management LP, Bain Capital Life Sciences Investors, LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.